EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV

Chuanyi Zhao, Meng Hao, Ting Bian, Xiaofan Zhao iD, Xiangyang Chi, Zhengshan Chen iD, Guangcheng Fu, Zheng Zhu, Ting Fang, Changming Yu, Jianmin Li iD, Wei Chen iD

Viruses · 2025

DOI: 10.3390/v17040559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Chuanyi Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Rift Valley fever virus, Antibodies, Viral, Rift Valley Fever. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rift Valley fever virus (RVFV) is a mosquito-transmitted bunyavirus that can cause substantial morbidity and mortality in livestock and humans, for which there are no currently available licensed human therapeutics or vaccines. Therefore, the development of safe and effective antivirals is both necessary and urgent. The Gc protein is the primary target of the neutralizing antibody response related to Rift Valley fever virus. Here, we report one Gc-specific neutralizing antibody (NA137) isolated from an alpaca and one bispecific antibody (E2-NA137), the protective efficacies of which we evaluated in A129 mice. In this prophylactic study, the survival rates of the NA137 and E2-NA137 groups were both 80%, and in the treatment study, the survival rates were 20% and 60%, respectively. Altogether, our results emphasize that NA137 and E2-NA137 provide a potential approach for treating RVFV either prophylactically or therapeutically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingRift Valley fever virusAntibodies, ViralRift Valley FeverViral ProteinsAnimalsMiceCamelids, New WorldFemaleDisease Models, Animal

Stichwörter der Autor:innen

Gc proteinRift Valley fever virus (RVFV)VHHbispecific antibody (bsAb)nanobody (Nb)neutralizing antibody (NAb)

Substanzen

Antibodies, NeutralizingAntibodies, ViralViral Proteins

Autor:innen und Institutionen

  • School of Medicine, Zhejiang University, Hangzhou 310058, China.
  • Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.

ORCID-Profile: Xiaofan Zhao, Zhengshan Chen, Jianmin Li, Wei Chen

Zitieren

APA

Zhao, C., Hao, M., Bian, T., Zhao, X., Chi, X., Chen, Z., Fu, G., Zhu, Z., Fang, T., Yu, C., Li, J., & Chen, W. (2025). Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV. Viruses. https://doi.org/10.3390/v17040559

Vancouver

Zhao C, Hao M, Bian T, Zhao X, Chi X, Chen Z, et al. Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV. Viruses. 2025. doi:10.3390/v17040559

BibTeX
@article{Zhao2025,
  author = {Zhao, Chuanyi and Hao, Meng and Bian, Ting and Zhao, Xiaofan and Chi, Xiangyang and Chen, Zhengshan and Fu, Guangcheng and Zhu, Zheng and Fang, Ting and Yu, Changming and Li, Jianmin and Chen, Wei},
  title = {Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17040559}
}
Kostenlos starten →